Rocket Doctor and Toronto Metropolitan University (TMU) have formed a strategic partnership to leverage the independent physicians on the Rocket Doctor platform to expand clinical education opportunities across TMU’s Medical School.Both organizations will collaborate on joint communications and create streamlined pathways for physicians on Rocket Doctor to engage with TMU and apply for clinical faculty roles.Rocket Doctor will promote and facilitate clinical faculty appointments, verify physician status, su ...

Core Insights - Mobile-health Network Solutions (MNDR) launched an at-the-market (ATM) equity offering to raise up to $300 million to accelerate the growth of its AI-powered digital health platform [1][3] - The company aims to use the proceeds to develop large language models for diagnostics, expand AI-driven teleconsultation services in Asia, and build a pharmacy delivery infrastructure [3][4] Financial Performance - MNDR reported revenue of $4.3 million for the six-month period ended December 31, 2024, down from $6.6 million in the same period a year earlier [4][5] - The decline in revenue was attributed to the closure of a clinic in Singapore, which reduced telemedicine service usage, although sales of medicine and medical devices increased [5] Strategic Initiatives - In the first half of 2025, MNDR secured $10 million in funding for its AI Agent, launched AI Notes for transcribing doctor-patient conversations, acquired Indonesian pharmacy and telehealth platform Lifepack, and announced plans for a tele-dentistry service [6] - The company is optimistic about recovering and surpassing previous revenue levels, aiming for breakeven by the second half of FY2025 and profitability before the first half of FY2027 [7] Market Trends - Telehealth has become a standard delivery channel in the U.S., particularly among younger generations, with nearly 30% of Generation Z and millennials using telehealth for their most recent healthcare encounter [8]